Forte Biosciences CEO Martin Duvall's 2018 pay falls 54% to $2M
Forte Biosciences reports 2018 executive compensation
By ExecPay News
Published: April 19, 2019
Forte Biosciences reported fiscal year 2018 executive compensation information on April 19, 2019.
In 2018, four executives at Forte Biosciences received on average a compensation package of $1.2M, a 49% decrease compared to previous year.
Average pay of disclosed executives at Forte Biosciences
Martin J. Duvall, Chief Executive Officer, received $2M in total, which decreased by 54% compared to 2017. 61% of Duvall's compensation, or $1.2M, was in option awards. Duvall also received $271K in non-equity incentive plan, $511K in salary, as well as $560 in other compensation.
Mark Foletta, Chief Financial Officer, received a compensation package of $1.2M, which decreased by 42% compared to previous year. 56% of the compensation package, or $701K, was in option awards.
Asha Das, Chief Medical Officer, earned $920K in 2018, a 55% decrease compared to previous year.
Douglas Jolly, Executive Vice President, Research and Pharmaceutical Development, received $623K in 2018, which decreases by 29% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 19, 2019.